Abnormal signal transduction

A hypothetical model for bipolar affective disorder

Herbert M. Lachman, Demitri F. Papolos

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The molecular basis of bipolar affective disorder is poorly understood at this time. The episodic nature of the condition in which relatively euthymic periods of variable duration separate periods of mania and depression, and the specificity of lithium therapy suggests that a molecular target of the illness may be a system that bidirectionally influences neurotransmission and is affected by lithium. Signal transduction pathways, which are important mediators of neurotransmitter generated signals, may represent such a system because they: 1) generate second messenger molecules that stimulate neurotransmission and also mediate negative feedback mechanisms, and 2) appear to be a direct target of lithium's action on cells. In this paper, we present a model in which abnormal regulation of signal transduction could lead to the episodic accumulation of biologically active transducers or second messengers. These alterations may result in prolonged effector stimulation which may underlie mania, followed by excessive receptor desensitization, which may result in depression. Using our model we suggest a plausible hypothesis that can explain the clinical spectrum of the disorder and the therapeutic action of lithium.

Original languageEnglish (US)
Pages (from-to)1413-1426
Number of pages14
JournalLife Sciences
Volume45
Issue number16
DOIs
StatePublished - 1989

Fingerprint

Signal transduction
Mood Disorders
Bipolar Disorder
Lithium
Signal Transduction
Second Messenger Systems
Synaptic Transmission
Depression
Transducers
Neurotransmitter Agents
Feedback
Molecules
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Abnormal signal transduction : A hypothetical model for bipolar affective disorder. / Lachman, Herbert M.; Papolos, Demitri F.

In: Life Sciences, Vol. 45, No. 16, 1989, p. 1413-1426.

Research output: Contribution to journalArticle

@article{2d8ed08b0e01496aaa91837d73a31cb9,
title = "Abnormal signal transduction: A hypothetical model for bipolar affective disorder",
abstract = "The molecular basis of bipolar affective disorder is poorly understood at this time. The episodic nature of the condition in which relatively euthymic periods of variable duration separate periods of mania and depression, and the specificity of lithium therapy suggests that a molecular target of the illness may be a system that bidirectionally influences neurotransmission and is affected by lithium. Signal transduction pathways, which are important mediators of neurotransmitter generated signals, may represent such a system because they: 1) generate second messenger molecules that stimulate neurotransmission and also mediate negative feedback mechanisms, and 2) appear to be a direct target of lithium's action on cells. In this paper, we present a model in which abnormal regulation of signal transduction could lead to the episodic accumulation of biologically active transducers or second messengers. These alterations may result in prolonged effector stimulation which may underlie mania, followed by excessive receptor desensitization, which may result in depression. Using our model we suggest a plausible hypothesis that can explain the clinical spectrum of the disorder and the therapeutic action of lithium.",
author = "Lachman, {Herbert M.} and Papolos, {Demitri F.}",
year = "1989",
doi = "10.1016/0024-3205(89)90031-3",
language = "English (US)",
volume = "45",
pages = "1413--1426",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Abnormal signal transduction

T2 - A hypothetical model for bipolar affective disorder

AU - Lachman, Herbert M.

AU - Papolos, Demitri F.

PY - 1989

Y1 - 1989

N2 - The molecular basis of bipolar affective disorder is poorly understood at this time. The episodic nature of the condition in which relatively euthymic periods of variable duration separate periods of mania and depression, and the specificity of lithium therapy suggests that a molecular target of the illness may be a system that bidirectionally influences neurotransmission and is affected by lithium. Signal transduction pathways, which are important mediators of neurotransmitter generated signals, may represent such a system because they: 1) generate second messenger molecules that stimulate neurotransmission and also mediate negative feedback mechanisms, and 2) appear to be a direct target of lithium's action on cells. In this paper, we present a model in which abnormal regulation of signal transduction could lead to the episodic accumulation of biologically active transducers or second messengers. These alterations may result in prolonged effector stimulation which may underlie mania, followed by excessive receptor desensitization, which may result in depression. Using our model we suggest a plausible hypothesis that can explain the clinical spectrum of the disorder and the therapeutic action of lithium.

AB - The molecular basis of bipolar affective disorder is poorly understood at this time. The episodic nature of the condition in which relatively euthymic periods of variable duration separate periods of mania and depression, and the specificity of lithium therapy suggests that a molecular target of the illness may be a system that bidirectionally influences neurotransmission and is affected by lithium. Signal transduction pathways, which are important mediators of neurotransmitter generated signals, may represent such a system because they: 1) generate second messenger molecules that stimulate neurotransmission and also mediate negative feedback mechanisms, and 2) appear to be a direct target of lithium's action on cells. In this paper, we present a model in which abnormal regulation of signal transduction could lead to the episodic accumulation of biologically active transducers or second messengers. These alterations may result in prolonged effector stimulation which may underlie mania, followed by excessive receptor desensitization, which may result in depression. Using our model we suggest a plausible hypothesis that can explain the clinical spectrum of the disorder and the therapeutic action of lithium.

UR - http://www.scopus.com/inward/record.url?scp=0024378597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024378597&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90031-3

DO - 10.1016/0024-3205(89)90031-3

M3 - Article

VL - 45

SP - 1413

EP - 1426

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 16

ER -